Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/13/20 | Others | Director | 109,372 | 0.1671% | ||
| 10/13/20 | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/10/20 | Tender | General Counsel | 391,686 | 0.5984% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.20% | - | - | 2.27B | |
| +4.35% | +16.60% | +58.11% | +95.21% | 62.53B | |
| +2.83% | -3.48% | +24.97% | +67.25% | 52.43B | |
| +0.91% | -0.83% | -17.01% | -13.43% | 23.1B | |
| +0.27% | -3.98% | -11.28% | +350.30% | 21.4B | |
| +2.07% | +9.58% | +30.99% | -5.54% | 21.17B | |
| +0.75% | +1.34% | +32.22% | -25.25% | 17.76B | |
| +9.88% | +23.61% | +222.87% | +385.49% | 15.47B | |
| +2.07% | +4.37% | +19.58% | +627.54% | 14.68B | |
| +1.25% | +2.48% | +51.36% | +179.72% | 14.08B | |
| Average | +2.40% | +4.45% | +45.76% | +184.59% | 26.96B | |
| Weighted average by Cap. | +2.87% | +5.40% | +41.19% | +139.34% |
Employees
-
